fostamatinib
Showing 1 - 25 of 58
Activity and Safety of Fostamatinib in Consecutive Adult ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- +2 more
- Fostamatinib
- (no location specified)
Jan 12, 2023
Fostamatinib in Patients With ITP. FOSTASUR Study
Completed
- Primary Immune Thrombocytopenia
- Fostamatinib
-
Cadiz, Cádiz, Spain
- +13 more
Oct 3, 2023
Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
- Sickle Cell Disease
- +5 more
- Fostamatinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2023
Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)
Recruiting
- Myelofibrosis
- Fostamatinib
- Ruxolitinib
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Hematological Malignancies Trial in Durham (fostamatinib)
Active, not recruiting
- Hematological Malignancies
- fostamatinib
-
Durham, North CarolinaDuke University of Medicine
Jul 14, 2022
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
- fostamatinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Ovarian Cancer Trial in Washington, Baltimore, Philadelphia (Fostamatinib and Paclitaxel)
Active, not recruiting
- Ovarian Cancer
- Fostamatinib and Paclitaxel
-
Washington, District of Columbia
- +2 more
Aug 10, 2022
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Immune Mediated Anemia
- +2 more
- fostamatinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Hidradenitis Suppurativa Trial in Sydney (Fostamatinib)
Recruiting
- Hidradenitis Suppurativa
- Fostamatinib
-
Sydney, New South Wales, AustraliaHoldsworth House Medical Practice
Mar 15, 2022
Coronavirus Disease 2019 Trial in Bethesda, Falls Church (Placebo, fostamatinib)
Completed
- Coronavirus Disease 2019
- Placebo
- fostamatinib
-
Bethesda, Maryland
- +1 more
Feb 28, 2022
Renal Transplant Rejection Trial in London (Fostamatinib)
Recruiting
- Renal Transplant Rejection
- Fostamatinib
-
London, United KingdomImperial College NHS Healthcare Trust
Oct 1, 2021
Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)
Recruiting
- Refractory Chronic Myelomonocytic Leukemia
- Refractory Myelodysplastic Syndrome
- Fostamatinib
-
Houston, TexasM D Anderson Cancer Center
Aug 31, 2021
Covid19, SARS (Severe Acute Respiratory Syndrome), SARS Pneumonia Trial in Worldwide (Fostamatinib, Placebo)
Active, not recruiting
- Covid19
- +5 more
- Fostamatinib
- Placebo
-
Orange, California
- +46 more
Aug 9, 2022
Adult Immune Thrombocytopenia and Insufficient Response toPrior
Recruiting
- ITP
- Immune Thrombocytopenia
- Fostamatinib
-
Springfield, Illinois
- +7 more
Jul 13, 2021
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium)
Enrolling by invitation
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
-
Los Angeles, California
- +36 more
Mar 2, 2022
Warm Antibody Autoimmune Hemolytic Anemia Trial in Canada, United States (Fostamatinib 150 mg bid)
Completed
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib 150 mg bid
-
Gilbert, Arizona
- +35 more
Jul 19, 2021
COVID-19, SARS-CoV2 Infection, Coronavirus Infection Trial in Worldwide (Fostamatinib, Placebo)
Recruiting
- COVID-19
- +2 more
- Fostamatinib
- Placebo
-
Porto Alegre, Brazil
- +20 more
Jan 6, 2023
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium, Placebo)
Active, not recruiting
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
- Placebo
-
Gilbert, Arizona
- +101 more
Nov 24, 2021
Immune Thrombocytopenic Purpura Trial in Worldwide (Fostamatinib Disodium)
Completed
- Immune Thrombocytopenic Purpura
- Fostamatinib Disodium
-
Tucson, Arizona
- +54 more
May 21, 2021
IGA Nephropathy Trial in Worldwide (Fostamatinib 150 mg, Fostamatinib 100 mg, Placebo)
Completed
- IGA Nephropathy
- Fostamatinib 150 mg
- +2 more
-
Palo Alto, California
- +19 more
Jun 10, 2019
Immune Thrombocytopenic Purpura Trial in Worldwide (Fostamatinib Disodium, Placebo)
Completed
- Immune Thrombocytopenic Purpura
- Fostamatinib Disodium
- Placebo
-
Nyack, New York
- +34 more
Jan 24, 2019
Immune Thrombocytopenic Purpura Trial (Fostamatinib disodium 100 mg, Fostamatinib disodium 150 mg)
No longer available
- Immune Thrombocytopenic Purpura
- Fostamatinib disodium 100 mg
- Fostamatinib disodium 150 mg
- (no location specified)
Jul 30, 2018
Immune Thrombocytopenic Purpura Trial in Worldwide (Fostamatinib disodium, Placebo)
Completed
- Immune Thrombocytopenic Purpura
- Fostamatinib disodium
- Placebo
-
Tucson, Arizona
- +51 more
Jan 24, 2019